Kathy Shire

1.2k total citations
18 papers, 1.0k citations indexed

About

Kathy Shire is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Kathy Shire has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Kathy Shire's work include Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Kathy Shire is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Kathy Shire collaborates with scholars based in Canada, United States and United Kingdom. Kathy Shire's co-authors include Lori Frappier, Tin Nguyen, Derek F. Ceccarelli, A.M. Edwards, Jack Liao, Feroz Sarkari, Yi Sheng, C.H. Arrowsmith, V. Saridakis and Weontae Lee and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Kathy Shire

18 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Shire Canada 13 568 530 315 157 150 18 1.0k
Feroz Sarkari Canada 9 518 0.9× 659 1.2× 228 0.7× 99 0.6× 120 0.8× 10 930
Meir Shamay United States 15 436 0.8× 349 0.7× 463 1.5× 101 0.6× 114 0.8× 31 912
Hari Raghu United States 11 364 0.6× 260 0.5× 276 0.9× 90 0.6× 165 1.1× 11 790
Josephine N. Harada United States 9 470 0.8× 460 0.9× 187 0.6× 81 0.5× 161 1.1× 11 893
David N. Everly United States 14 364 0.6× 388 0.7× 482 1.5× 132 0.8× 335 2.2× 18 1.0k
Prasanna M. Bhende United States 9 394 0.7× 235 0.4× 199 0.6× 134 0.9× 126 0.8× 10 631
Satoko Iwahori Japan 21 442 0.8× 366 0.7× 458 1.5× 60 0.4× 134 0.9× 31 922
Abhik Saha India 20 921 1.6× 388 0.7× 529 1.7× 281 1.8× 236 1.6× 41 1.3k
Christopher B. Whitehurst United States 16 391 0.7× 282 0.5× 264 0.8× 116 0.7× 153 1.0× 22 676
Robert Touitou United Kingdom 10 528 0.9× 302 0.6× 145 0.5× 212 1.4× 158 1.1× 10 742

Countries citing papers authored by Kathy Shire

Since Specialization
Citations

This map shows the geographic impact of Kathy Shire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Shire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Shire more than expected).

Fields of papers citing papers by Kathy Shire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Shire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Shire. The network helps show where Kathy Shire may publish in the future.

Co-authorship network of co-authors of Kathy Shire

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Shire. A scholar is included among the top collaborators of Kathy Shire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Shire. Kathy Shire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cruz-Herrera, Carlos F. de la, Michael H. Tatham, Kathy Shire, et al.. (2023). Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1. PLoS Pathogens. 19(7). e1011477–e1011477. 10 indexed citations
2.
Airo, Adriana M., Valeria Mancinelli, Danyel Evseev, et al.. (2022). Flavivirus Capsid Proteins Inhibit the Interferon Response. Viruses. 14(5). 968–968. 11 indexed citations
3.
Shire, Kathy, et al.. (2022). G 1 /S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B. Journal of Virology. 96(18). e0066022–e0066022. 7 indexed citations
4.
Shire, Kathy, Edyta Marcon, Jack Greenblatt, & Lori Frappier. (2021). Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3. Virology. 562. 103–109. 10 indexed citations
5.
Cruz-Herrera, Carlos F. de la, et al.. (2018). A genome-wide screen of Epstein-Barr virus proteins that modulate host SUMOylation identifies a SUMO E3 ligase conserved in herpesviruses. PLoS Pathogens. 14(7). e1007176–e1007176. 30 indexed citations
6.
Shire, Kathy, et al.. (2015). Identification of RNF168 as a PML nuclear body regulator. Journal of Cell Science. 129(3). 580–591. 17 indexed citations
7.
Cao, Jennifer Yinuo, et al.. (2013). Identification of a Novel Protein Interaction Motif in the Regulatory Subunit of Casein Kinase 2. Molecular and Cellular Biology. 34(2). 246–258. 24 indexed citations
8.
Nguyen, Tin, Madhav Jagannathan, Kathy Shire, & Lori Frappier. (2012). Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4. PLoS ONE. 7(4). e35931–e35931. 12 indexed citations
9.
Shire, Kathy, et al.. (2009). Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). Journal of Cell Science. 122(23). 4341–4350. 45 indexed citations
10.
Wang, Shan, et al.. (2008). The EBNA1 Protein of Epstein-Barr Virus Functionally Interacts with Brd4. Journal of Virology. 82(24). 12009–12019. 85 indexed citations
11.
Sakwe, Amos M., Tin Nguyen, Vicki Athanasopoulos, Kathy Shire, & Lori Frappier. (2007). Identification and Characterization of a Novel Component of the Human Minichromosome Maintenance Complex. Molecular and Cellular Biology. 27(8). 3044–3055. 53 indexed citations
12.
Hegde, Nagendra R., Mathieu S. Chevalier, Todd W. Wisner, et al.. (2006). The Role of BiP in Endoplasmic Reticulum-associated Degradation of Major Histocompatibility Complex Class I Heavy Chain Induced by Cytomegalovirus Proteins. Journal of Biological Chemistry. 281(30). 20910–20919. 46 indexed citations
13.
Shire, Kathy, et al.. (2006). Regulation of the EBNA1 Epstein-Barr Virus Protein by Serine Phosphorylation and Arginine Methylation. Journal of Virology. 80(11). 5261–5272. 58 indexed citations
14.
Saridakis, V., Yi Sheng, Feroz Sarkari, et al.. (2005). Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1. Molecular Cell. 18(1). 25–36. 284 indexed citations
15.
Cruickshank, Jennifer, Kathy Shire, Alan R. Davidson, A.M. Edwards, & Lori Frappier. (2000). Two Domains of the Epstein-Barr Virus Origin DNA-binding Protein, EBNA1, Orchestrate Sequence-specific DNA Binding. Journal of Biological Chemistry. 275(29). 22273–22277. 41 indexed citations
16.
Huber, Michael D., et al.. (2000). The Budding Yeast Homolog of the Human EBNA1-binding Protein 2 (Ebp2p) Is an Essential Nucleolar Protein Required for Pre-rRNA Processing. Journal of Biological Chemistry. 275(37). 28764–28773. 53 indexed citations
17.
Shire, Kathy, et al.. (1999). EBP2, a Human Protein That Interacts with Sequences of the Epstein-Barr Virus Nuclear Antigen 1 Important for Plasmid Maintenance. Journal of Virology. 73(4). 2587–2595. 139 indexed citations
18.
Shire, Kathy, et al.. (1994). Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block.. PubMed. 9(4). 1187–93. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026